Equities

Genomma Lab Internacional SAB de CV

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Genomma Lab Internacional SAB de CV

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (MXN)20.30
  • Today's Change0.38 / 1.91%
  • Shares traded5.95m
  • 1 Year change+12.90%
  • Beta0.4922
Data delayed at least 20 minutes, as of Jul 15 2025 20:13 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade, Genomma Lab Internacional SAB de CV (LABB:MEX) traded at 20.30, 19.55% above the 52 week low of 16.98 set on Jul 19, 2024.
52-week range
Today
16.98Jul 19 202429.18Feb 12 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open19.82
High20.40
Low19.82
Bid20.30
Offer20.31
Previous close19.92
Average volume3.30m
Shares outstanding1.00bn
Free float734.62m
P/E (TTM)8.75
Market cap19.92bn MXN
EPS (TTM)2.28
MXN
Annual div (ADY)0.6167
MXN
Annual div yield (ADY)3.10%
Div ex-dateJun 30 2025
Div pay-dateJul 01 2025
Data delayed at least 20 minutes, as of Jul 15 2025 20:13 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.